Prostate Brachytherapy Boost: Where Are We and Where Are We Going
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation
Reference13 articles.
1. Long-term results of NRG oncology/RTOG 0321: A phase II trial of combined high dose rate brachytherapy and external beam radiation therapy for adenocarcinoma of the prostate;Hsu;Int J Radiat Oncol Biol Phys,2020
2. An updated analysis of survival endpoints for ASCENDE-RT, a randomized trial comparing a low-dose-rate brachytherapy boost to a dose-escalated external beam boost for high-and intermediate-risk prostate cancer;Oh;Int J Radiat Oncol Biol Phys,2020
3. Randomised trial of external-beam radiotherapy alone or with high-dose-rate brachytherapy for prostate cancer: Mature 12-year results;Hoskin;Radiother Oncol,2020
4. Duration of androgen suppression before radiotherapy for localized prostate cancer: Radiation therapy oncology group randomized clinical trial 9910;Pisansky;J Clin Oncol,2015
5. Short-term adjuvant versus neoadjuvant hormone therapy in localized prostate cancer: A pooled individual patient analysis of two phase III trials;Spratt;J Clin Oncol,2020
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3